Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Juni 2015 11:30 ET | Quelle: N8 Medical, Inc.

N8 Medical to Split Medical Device and Pharmaceutical Businesses

COLUMBUS, Ohio, June 5, 2015 (GLOBE NEWSWIRE) -- N8 Medical, an emerging pharmaceutical company addressing life-threatening global health challenges through the development of high-value...
04. März 2015 09:40 ET | Quelle: N8 Medical, Inc.

Recently Published Study Demonstrates That CSA-90 May Promote Osteogenesis and Prevent Staphylococcus aureus Infection in Preclinical Models

COLUMBUS, Ohio, March 4, 2015 (GLOBE NEWSWIRE) -- N8 Medical, an emerging pharmaceutical company addressing life-threatening global health challenges through the development of high-value...
01. Dezember 2014 09:45 ET | Quelle: N8 Medical, Inc.

Recently Published Reviews Highlight the Potential Utility of Ceragenins in the Fight Against Biofilm Mediated and Multidrug Resistant Bacterial Infections

COLUMBUS, Ohio, Dec. 1, 2014 (GLOBE NEWSWIRE) -- N8 Medical, an emerging pharmaceutical company addressing life-threatening global health challenges through the development of high-value...
09. Oktober 2014 09:45 ET | Quelle: N8 Medical, Inc.

N8 Respiratory Presents Data Demonstrating Antimicrobial Efficacy of CSA-13 Against Psuedomonas Aeruginosa Biofilm

COLUMBUS, Ohio, Oct. 9, 2014 (GLOBE NEWSWIRE) -- N8 Respiratory, LLC., (a subsidiary of N8 Medical, Inc.) an emerging respiratory therapeutics company focused on the development of ceragenins as...
23. Juni 2014 09:45 ET | Quelle: N8 Medical, Inc.

N8 Respiratory Hires Industry Leader as Chief Operating Officer

COLUMBUS, Ohio, June 23, 2014 (GLOBE NEWSWIRE) -- N8 Respiratory, LLC., a subsidiary of N8 Medical, Inc., an emerging pharmaceutical company focused on developing anti-infective therapies for...